Md. Code, Ins. §§ 15-1633 through 15-1639: Pharmacy Benefit Managers, Part VI Therapeutic Interchanges – Maryland

Status: Enacted
Year Enacted: 2008
File: Download

In any therapeutic interchange solicitation, the following shall be disclosed to the prescriber: that a therapeutic interchange is being solicited, the circumstances under which the originally prescribed drug will be covered by the purchaser, the difference in copayments or coinsurance to be paid by the beneficiary to obtain the proposed drug, the circumstances and extent to which health care costs related to the therapeutic interchange will be compensated, and any clinically significant differences, as determined by a pharmacy and therapeutics committee of the pharmacy benefits manager, with respect to efficacy, side effects, and potential impact on health and safety.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found